Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Allergy|March 3, 2016
Identification of STOML2 as a putative novel asthma risk gene associated with IL6RJ A Revez, M C Matheson, J Hui, et al.
Breast Cancer Research and Treatment|July 25, 2013
Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over timeG L Chew, D Huang, C W Huo, et al.
Journal of the National Cancer Institute|October 19, 2000
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle, J L Hopper, G S Dite, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2017
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriersY C Lee, R L Milne, S Lheureux, et al.
Breast Cancer Research and Treatment|October 22, 2014
Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambersG L Chew, C W Huo, D Huang, et al.
Cancer Research|April 23, 1999
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based studyJ E Armes, L Trute, D White, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 4, 2009
Relevance of the hygiene hypothesis to early vs. late onset allergic rhinitisM C Matheson, E H Walters, J A Simpson, et al.
Prostate Cancer and Prostatic Diseases|April 19, 2017
Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case-control studyN P Papa, R J MacInnis, H Jayasekara, et al.
Carcinogenesis|April 21, 2010
Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer riskE A Tindall, G Severi, H N Hoang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancerK M Field, M A Jenkins, M L Friedlander, et al.
Pageof 23